De novo mutations in the MiDAC HDAC complex cause a neurodevelopmental syndrome resulting from increased deacetylase activity

MIDEAS is a scaffold protein that, together with DNTTIP1, mediates assembly of the MiDAC histone deacetylase complex. Mice lacking MiDAC die before birth suggesting a key developmental function. Here, we report two unrelated individuals, with a multisystem disorder characterized by delayed speech development, joint contractures, dysmorphic features and dysmotility of the gut. Both individuals have the same de novo heterozygous mis-sense variant in MIDEAS (Tyr654Ser). A cryoEM structure of the MiDAC complex reveals that this amino acid is located in a conserved auto-inhibitory loop that covers the active site of the deacetylase enzyme. We suggest that the mutation results in loop displacement leading to elevated deacetylase activity. In support, we observe reciprocal gene expression changes in patient fibroblasts compared with a cell line following rapid MiDAC degradation. Our results establish Mideas as a novel dominant monogenic disease gene and that hyperactivity of the MiDAC complex results in a characteristic multisystem disorder.

Publication Details

Journal
University of Birmingham Research Portal (University of Birmingham)
Published
2025-10-09
Primary Topic
Genomics and Rare Diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

De novo mutations in the MiDAC HDAC complex cause a neurodevelopmental syndrome resulting from increased deacetylase activity

University of Birmingham Research Portal (University of Birmingham)
Genomics and Rare Diseases
article

De novo mutations in the MiDAC HDAC complex cause a neurodevelopmental syndrome resulting from increased deacetylase activity

article en

Abstract

MIDEAS is a scaffold protein that, together with DNTTIP1, mediates assembly of the MiDAC histone deacetylase complex. Mice lacking MiDAC die before birth suggesting a key developmental function. Here, we report two unrelated individuals, with a multisystem disorder characterized by delayed speech development, joint contractures, dysmorphic features and dysmotility of the gut. Both individuals have the same de novo heterozygous mis-sense variant in MIDEAS (Tyr654Ser). A cryoEM structure of the MiDAC complex reveals that this amino acid is located in a conserved auto-inhibitory loop that covers the active site of the deacetylase enzyme. We suggest that the mutation results in loop displacement leading to elevated deacetylase activity. In support, we observe reciprocal gene expression changes in patient fibroblasts compared with a cell line following rapid MiDAC degradation. Our results establish Mideas as a novel dominant monogenic disease gene and that hyperactivity of the MiDAC complex results in a characteristic multisystem disorder.

University of Birmingham Research Portal (University of Birmingham)
Wellcome Trust, University of Leicester, Universitair Medisch Centrum Utrecht
Openalex Percentile: Top 28%
Genomics and Rare Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

De novo mutations in the MiDAC HDAC complex cause a neurodevelopmental syndrome resulting from increased deacetylase activity · University of Birmingham Research Portal (University of Birmingham) (2025) | TGRS Research Map | TGRS